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ABSTRACT 
Caspase-2 is the best conserved member of the caspase family. Although being known to 
mediate cell death following DNA damage, many studies have implicated that this protease 
regulates a variety of cellular processes. Despite this, few well-defined and mechanistically 
explained functions of caspase-2 has been described. In an attempt to shed light on this 
enigma, we performed a yeast two-hybrid screen, searching for interaction partners of 
caspase-2 which could explain many of the reported observations. From the screen two hits 
stood out, relating to the proteins RFXANK and FAN. In the first study we investigated the 
relationship between caspase-2 and RFXANK, a protein known for regulating expression of 
MHC class II genes. The interaction between the two proteins was confirmed to take place 
primarily in the cytoplasm of cells. Caspase-2 was able to bind to a construct resembling the 
four ankyrin repeats of RFXANK, indicating that this is the region important for the 
interaction. Cells lacking caspase-2 contained higher total levels of MHC II, thereby 
suggesting that caspase-2 suppresses normal expression of the complex. Surprisingly, 
antigen-presenting cells from caspase-2-/- mice did not display any differences in surface 
distribution of the MHC II, indicating that the transport of MHC II from the cell interior to 
the exterior was somehow impaired. In the second study, we were interested in the 
understanding of the relationship between caspase-2 and FAN. Like in the first study, the 
interaction between the two proteins was confirmed by methodologies separated from yeast 
two-hybrid. FAN is a protein which has been reported to regulate a wide range of processes. 
We, therefore, systematically evaluated how a lack of caspase-2 would affect cells, while 
comparing to what is known about FAN-deficiency. Interestingly, we found that loss of 
caspase-2 caused the same outcomes as has been described for cells which have lost FAN. 
Notably, the ability to secrete IL-6 was greatly impaired in caspase-2-deficient cells, when 
comparing with relevant controls. Furthermore, enzyme-deficient cells took longer time to 
repopulate cell-free areas, indicating hampered cell motility. Although FAN is known to also 
regulate ceramide production, we did not observe any differences in sphingolipid contents 
when removing caspase-2. We did, however, observe that caspase-2-deficient cells contained 
abnormally enlarged vesicular/lysosomal structures, similar to what has been described 
following loss of FAN. In the third study we investigated the potential involvement of 
caspase-2 in the cell death process induced by Gemtuzumab ozogamicin (GO; Mylotarg®). 
This was based on the fact that GO causes DNA damage, a cause known to activate the 
proapoptotic function of caspase-2. We found that inhibition or removal of caspase-2 
protected AML cells from GO-induced apoptosis. Strikingly, caspase-2 appeared to be 
involved in the processing of BID, but not the activation of BAX following treatment with 
GO. This may imply that the protease acts in parallel with GO, mainly by increasing the 
effect of the drug rather than being vital for the drug toxicity.  
Taken together we describe novel interaction partners to caspase-2 and highlight how the 
protease may regulate processes which are not necessarily tied with apoptosis.  
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1 INTRODUCTION 
The reciprocal relationship between life and death 
Since the dawn of medical research, the goal has been to understand the physiology and 
pathophysiology of humans, in order to prevent, treat and abolish ailments, diseases and 
disorders. This seemingly never-ending quest has resulted in improved life conditions, which 
in turn has extended the average human life span. Despite this, it remains difficult to define 
what life is in a precise, unquestionable and undeniable term, whether from a theological or 
scientific viewpoint. What most people agree on is that there are certain attributes which 
living beings fulfill. Based on this, one could define life as being a state in which an entity 
independently is able to interact with its own environment and/or other entities, in order to 
maintain its own existence and/or that of another. Consequently, the understanding of death, 
i.e. the cessation of life, becomes fundamental in order to achieve new medical 
breakthroughs. This became notably apparent upon the realization that cells may die in a non-
accidental, programmed fashion as a result of both normal and abnormal causes. Cell death 
has been reported as far back as in 1842 by Carl Vogt, who observed dying cells in the 
notochord and cartilage of metamorphic toads. Vogt sadly failed to realize the importance of 
this naturally occurring cell elimination observed in his model. Likewise, throughout the 
following decades, cell death during insect metamorphosis was either overlooked or 
misinterpreted (Clarke and Clarke, 1996). However, in present times, the phenomenon of 
controlled cell death has become recognized as being vital for an organism’s health and 
development. Conversely, dysregulation of controlled cell death can give rise to many 
diseases and disorders. Philosophically, this signifies the intricacy between life and death, as 
well as health and disease. It is, therefore, not without irony that mankind, in an attempt to 
extend life, inevitably has to study death. 
 
Cell death 
Cells in our bodies have a finite life span. Similarly to how old or broken parts of a machine 
eventually need to be replaced, so do the cells. A cell which has sustained damage typically 
attempts to repair itself. The cellular response towards the injury depends on the cause and 
severity. For example, DNA-damage following radiation normally activates various DNA 
repair systems (Norbury and Hickson, 2001), while damaged or unneeded proteins are 
degraded to avoid a buildup which could potentially become harmful for the cell. Should the 
extent of an injury exceed the cell’s capability of self-repair, it triggers a “self-destructing” 
signal, leading to its breakdown and removal. Likewise, senescent cells have reached a point 
to where telomere shortening triggers the DNA damage response, causing the same outcome. 
This sacrificial programming is important for multi-cellular organisms in order to prevent 
abnormal and malfunctioning cells from replicating, which could otherwise give rise to 
severe pathological conditions. Besides from maintaining the cellular homeostasis, cell death 
also plays a vital role during the developmental stages of multicellular organisms (Elmore, 
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2007, Fuchs and Steller, 2011). For instance, cell death is the underlying mechanism that 
removes interdigital webs in higher vertebrates, thereby forming the organism’s digits 
(Lindsten et al, 2000). Similarly, it is essential for formation of the neural tube during 
development of the central nervous system (Glücksmann, 1951). 
Defective cells often suffer from faulty cell death machineries. This may allow cells to either 
escape elimination or, at least, require higher degrees of stimulus in order to accomplish cell 
death. This is most notably the case for tumorigenic cells. In contrast, too much cell death 
may cause a loss of vital cell types, as well as abrogated tissue functions (King and 
Cidlowski, 1998), which is the case of many neurodegenerative disorders (Lang-Rollin et al, 
2003). The term “cell death” encompasses several different modalities by which cells are 
eliminated. Based on the various biochemical and morphological features displayed by dying 
cells, the Nomenclature Committee on Cell Death (NCCD) proposed recommendations for 
accurate classification of the many modes of cell death (Kroemer et al, 2005). Arguably the 
most studied and best described modes include apoptosis, autophagy and necrosis.  
 
Apoptosis 
The term “programmed cell death” (PCD), introduced by Lockshin and Williams in 1965, is 
commonly used while referring to the process known as apoptosis (Lockshin and Williams, 
1965, Kerr et al, 1972, Elmore, 2007). This is one of the most studied subjects within the 
field of cell biology (Wong, 2011). Hallmarks of apoptosis include protein cleavage, DNA 
fragmentation and morphological changes such as cell shrinkage and the formation of 
apoptotic bodies with an undamaged membrane. These changes culminate in the removal of 
the dying cell(s) by phagocytic cells (Elmore 2007, Hengartner, 2000), recruited and 
activated by “eat me” signals in the final stages of the apoptotic process. The key mediators 
of apoptosis are members from a family of cysteine proteases called caspases. However, not 
all caspases are pro-apoptotic. For instance, caspase-1, -4, -5 and -11 all play various roles in 
inflammatory responses (Jiménez Fernández and Lamkanfi, 2015), while caspase-14 is 
important for keratinocyte differentiation (Rendl et al, 2002). Apoptotic caspases are 
classified into two groups, initiator and effector caspases. The initiator caspases (caspase-2, -
8 and -9) generally become recruited to larger complexes as zymogens, leading to their 
proximity-induced activation. Subsequently, the initiators may bring about the cleavage and 
activation effector caspases (caspase-3, -6 or -7) in turn. The pro-apoptotic caspases cleave 
specific substrates at aspartate residues, causing the breakdown of cellular structures, 
ultimately resulting in the shrinkage of the dying cell. Recent experimental evidence suggests 
that caspase substrates may include up to 1300 different human proteins (Crawford et al, 
2013). Some of these caspase-targets are proteins which are protecting cells from apoptosis. 
An example of this is Inhibitor of caspase-activated DNase/DNA fragmentation factor 
subunit alpha (ICAD/DFF45), which becomes cleaved by caspase-3, thereby allowing DNA 
fragmentation to commence (Thornberry and Lazebnik, 1998). Similarly, caspase-mediated 
cleavage of the anti-apoptotic protein B-cell lymphoma 2 (BCL-2) releases the repression of 
apoptosis, thereby causing cell death (Cheng et al, 1997). Other targets cleaved by caspases 
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include lamins and cytoskeletal-regulatory proteins (Takahashi et al, 1996, Kothakota et al, 
1997).  
Apart from caspases, other important regulators of apoptosis include members of the BCL-2 
family. These proteins are divided into three groups, depending of their individual 
composition of up to four different BCL-2 homology (BH) domains (Adams and Cory, 
1998). Pro-survival members, such as BCL-2, BCL-XL and MCL-1, contain all four variants 
of the BH domains. Pro-apoptotic members contain either BH1-3, such as BAX and BAK, or 
only the BH3 domain. BH3-only proteins include BIM, BID, NOXA and PUMA (Adams and 
Cory, 1998, Czabotar et al, 2014). BAX and BAK form pores in the mitochondrial outer 
membrane upon activation, while BH3-only proteins (with the exception of BID) generally 
inhibit anti-apoptotic proteins in order to promote BAX and BAK (Westphal et al, 2011, 
Shamas-Din et al, 2011). 
 
Figure 1. An overview of apoptotic processes.  
Image reused with permission from BioMed Central Ltd (Schleich and Lavrik, 2013). 
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Several different apoptotic molecular routes are known, namely the extrinsic, intrinsic and 
perforin/granzyme B pathways. In addition, a separate, caspase-2-mediated pathway exists, 
which is initiated following DNA damage. Although initially being triggered by different 
causes, the pathways converge upon the activation of caspase-3 (Elmore, 2007). The extrinsic 
pathway starts at the cell surface and involves death receptor-mediated signaling following 
stimulation with cognate ligands such as FasL, Tumor necrosis factor alpha (TNF-α) or TNF-
related apoptosis-inducing ligand (TRAIL). Conversely, the intrinsic pathway triggers upon 
internal stimulation, resulting in the opening of the mitochondrial permeability transition pore 
and loss of the mitochondrial transmembrane potential. As an outcome, several pro-apoptotic 
proteins such as cytochrome c are released into the cytoplasm, eventually leading to caspase 
activation. The perforin/granzyme B pathway is triggered by cytotoxic T-cells (CTLs) in 
virus-infected cells or tumor cells. Initially, the pore-forming protein perforin is secreted by 
CTLs and forms a transmembrane pore in the affected cell. This is followed by the release of 
cytoplasmic granules from CTLs, which enter the target cell through the pore. The granules 
contain the protease granzyme B which cleaves various target molecules, such as BID, ICAD 
and caspase-3. It should be noted that the granules contain other granzymes in addition to 
granzyme B, although only the latter induces apoptotic cell death (Elmore, 2007, Trapani and 
Smyth, 2002, Lieberman and Fan, 2003). 
Autophagy 
Another form of controlled cell death is the “self-eating” process called autophagy. Several 
forms of autophagy exist, albeit the form most often referred to is macroautophagy. This 
modality can either promote survival or death of a cell by degrading the bulk, organelles 
and/or proteins. During periods of moderate stress, such as starvation, it may be sufficient to 
reduce some of the cellular content in order to generate the nutrients required for extended 
survival. However, following severe stress, extensive removal of organelles and proteins may 
lead to cell death (Yonekawa and Thorburn, 2013, Yin et al, 2016). Central for the autophagic 
machinery is a group of proteins denoted ATG (autophagy-related). These proteins are 
involved in the formation of a double layered membranous structure called the 
autophagosome, which engulfs the cytoplasmic contents designated for destruction. 
Following a series of events, during which it maturates, the autophagosome eventually fuses 
with a lysosome and, by doing so, exposes the contents to lysosomal proteases for 
degradation (Mizushima et al, 2002, 2011). 
Necrosis 
Necrosis is a type of cell death which does not display the features of apoptosis or autophagy. 
In contrast to apoptotic cells, necrotic cells swell and suffer early ruptures in the plasma 
membrane. This leads to a release of cellular contents, which in turn trigger the innate 
immune response, thereby causing localized inflammation (Golstein and Kroemer, 2006, 
Vanden Berghe et al, 2014). Cells subjected to extremely harsh conditions, e.g. during 
exposure to detergents, typically die in a non-regulated necrotic fashion (Golstein and 
Kroemer, 2006). As a result, necrosis has long been regarded as an uncontrolled cell death 
process, occurring when cells take non-physiological damage. This view has partially 
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changed due to the fact that necrotic death can be induced upon inhibition of caspases (thus 
steering away from apoptosis). Similar to PCD, necrosis has also been observed during 
development as well as in the tissue homeostasis of adults (Roach and Clarke, 2000, Barkla 
and Gibson, 1999). Furthermore, TNF-α-mediated signaling can also bring about necrosis in 
addition to apoptosis, thus regulating two seemingly different cell death modalities. Taken 
together it becomes apparent that programmed necrosis (necroptosis) too is a controlled 
process, and not only a random, unchecked outcome caused by overwhelming cellular 
damage (Festjens et al, 2006). 
 
p53 
Multicellular organisms require healthy cells in order to avoid succumbing to pathologies. 
Cells have therefore developed various processes to ensure that only healthy and viable cells 
are allowed to propagate. While cell death is a means to eliminate cells that are beyond 
“saving”, other mechanisms exist which recognize potentially harmful damage and attempts 
to fix it. Central in many of these processes is the tumor suppressor p53. Due to the role in 
maintaining genomically healthy cells, p53 has thus been dubbed the “guardian of the 
genome” (Lane, 1992). Following DNA damage, p53 is responsible for the activation of 
several DNA-repair factors, as wells as halting the cell cycle to allow time for repair (Brady 
and Attardi, 2010). Furthermore, p53 is a master regulator of both the intrinsic and extrinsic 
apoptotic pathways, where it can drive the expression of pro-apoptotic members of the BCL-
2 family, e.g. BAX and NOXA, in addition to regulating the surface expression of death 
receptors (Vogelstein et al, 2000). It should also be noted that p53 can regulate other cell 
death modalities, such as necroptosis and ferroptosis. Being essential for proper surveillance 
and maintenance of the genome, it is not surprising that loss of p53 function may lead to 
tumor formation. In fact, mutations in the p53 gene (TP53) or p53-regulated pathways are 
found in the majority of all human cancers (Zilfou and Lowe, 2009, Joerger and Fersht, 
2016).   
 
Non-apoptotic functions of caspases 
As mentioned previously, not all caspases function in a pro-apoptotic manner. Some caspases 
mediate other cell death mechanisms in addition to apoptosis, such as autophagy, necroptosis 
and pyroptosis (Shalini et al, 2015a). Other caspases perform functions that are not directly 
linked with cell death, at least not during the initial steps. An example is caspase-1, which is 
important both for the inflammatory and innate immune responses, where it processes 
interleukins (IL) -18 and -33, and promotes IL-1β secretion (Kuranaga and Miura, 2007, 
Nadiri et al, 2006). Moreover, even well-established apoptotic caspases have been shown to 
perform functions which are not necessarily tied with cell death execution. These functions 
include roles in regulation of cell migration, proliferation and differentiation. Caspase-8 is 
seemingly involved in calpain-activation and cell migration of mouse embryonic fibroblasts 
(MEFs) (Helfer et al, 2006). Furthermore, caspase-8 appears to regulate the proliferation of 
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lymphocytes. Patients carrying mutations in caspase-8 often display defects in the activation 
of T-cells, B-cells and natural killer (NK) cells (Chun et al, 2002). Caspase-3, on the other 
hand, can cleave the cell cycle regulators p27 and p21, thereby promoting or inhibiting 
proliferation, respectively (Frost et al, 2001, Woo et al, 2003). Both caspase-3 and -8 appear 
to be required for differentiation of certain cells. While loss of caspase-8 prevents the 
differentiation of monocytes into macrophages (Kang et al, 2004), caspase-3-deficiency 
results in decreased osteogenic differentiation of bone marrow stromal cells (Miura et al, 
2004). Caspase-3 furthermore appears to be important for erythropoiesis and maturation of 
erythroid cells (Carlile et al, 2004), although caspase-3-mediated cleavage of GATA-1 has 
been shown to negatively regulate erythroblast differentiation (Zermati et al, 2001, Solier et 
al, 2017). In addition, as was previously mentioned, caspase-14 is important for keratinocyte 
differentiation and skin barrier formation (Rendl et al, 2002).  
Caspases are also known to be important during tissue regeneration, neural development, as 
well as in the pathophysiology of many neurodegenerative diseases (Shalini et al, 2015a, 
Mukherjee and Williams, 2017, Miura, 2012). Liver regeneration in mice seems to be 
dependent on the cleavage of iPLA2 by caspase-3 and -7, bringing about the secretion of 
PGE2 and subsequent tissue restoration (Li et al, 2010). Similarly, the two Drosophila 
melanogaster caspases, DrICE and Dcp-1, induces compensatory proliferation in eye tissues, 
following cell loss due to injuries (Fan and Bergmann, 2008). The D. melanogaster caspase 
Dronc, on the other hand, is pivotal for dendrite pruning and the development of the adult 
nervous system (Kuo et al, 2006). Human caspases have also been reported to cleave 
huntingtin and β-amyloid precursor protein (APP), which is believed to contribute towards 
developing Huntington’s disease and Alzheimer’s disease, respectively (Wellington and 
Hayden, 2000). Together, these findings show that caspases are highly versatile in nature, and 
may be important for many regulatory processes. 
  
  7 
2 INTRODUCTION TO THE STUDY 
Caspase-2 
In 1992, Kumar and co-workers first described a set of genes which were expressed during 
early embryonic mouse brain development, yet downregulated in adult mice. The team 
denoted these as nedd genes, based on the neural precursor cells from which they originated, 
as well as their expressional status. Amongst these, the nedd-2, -9, and -10 mRNA transcripts 
were undetectable in the adult mouse brain (Kumar et al, 1992). A year later, Horvitz and 
colleagues reported that the Caenorhabditis elegans gene, ced-3, encodes a protein bearing 
strong resemblance to ICE (later denoted as caspase-1) and the product of nedd-2. Based on 
the importance of ced-3 for programmed cell death in C. elegans, the group predicted that 
potential protein members belonging to the CED-3/ICE family might function as apoptotic 
regulators (Yuan et al, 1993). Later, it was shown that nedd-2 overexpression in fibroblasts 
and neuroblastoma cells resulted in an induction of apoptosis, which could be prevented 
when co-expressing human bcl-2 (Kumar et al, 1994). Furthermore, both nedd-2 and its 
human homologue ich-1, encoded proteins with sequences similar to ICE and CED-3 (Wang 
et al, 1994). Eventually, following the introduction of the term “caspase”, NEDD-2/ICH-1 
was renamed caspase-2 (Alnemri et al, 1996). 
Amongst the caspase protein family, caspase-2 is the most conserved member throughout 
evolution (Yuan et al, 1993, Kumar et al, 1994). This suggests that the role of the protein 
provide organisms with an advantage, thereby making the gene beneficial to harbor. Despite 
this, the main function of caspase-2 is still a subject of debate, as many different roles have 
been proposed. On top of it all, knock-out mice are viable and do not display any clearly 
overt phenotype, further questioning the degree of importance of caspase-2. It might, 
therefore, be possible that the protein functions as a fine-tuning factor in given modalities, 
potentially by increasing and augmenting the effectiveness of the cellular processes. 
 
Structure and activation 
The full structure of caspase-2 consists of a large subunit (p19) containing the active site, and 
a small subunit (p12). In addition, caspase-2 contains a caspase activation and recruitment 
domain (CARD) located towards the N-terminus. The identification of a classical nuclear 
localizing signal (NLS) at the C-terminus of the caspase-2 pro-domain explained why this 
particular caspase is able to localize to cell nuclei (Baliga et al, 2003). When comparing the 
structure with its other protein family members, caspase-2 is most similar to caspase-9 (Fava 
et al, 2012). These features classify the protease as belonging to the group of initiator 
caspases. However, unlike “typical” initiators, caspase-2 does not appear to cleave effector 
caspases, which is the case for caspase-8 and -9 (Fava et al, 2012, Guo et al, 2002). 
As with other initiator caspases, caspase-2 molecules can undergo autocatalytic cleavage 
when brought into close proximity of each other, therefore, making ectopic expression of the 
protein difficult as it might trigger the apoptotic machinery (Butt et al, 1998). Under natural 
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conditions, caspase-2 has been reported to undergo activation through a complex called the 
PIDDosome, which is typically formed as a result of DNA damage (Tinel and Tschopp, 
2004). This activation platform contains p53-induced death domain protein (PIDD) and RIP-
associated ICH-1/CED-3-homologous protein with death domain (RAIDD) in addition to 
pro-caspase-2. While PIDD and RAIDD interact through their death domains (DDs), RAIDD 
furthermore possesses a CARD, to which procaspase-2 binds using its own prodomain 
CARD. It has been shown that a layer of five PIDD death domains can interact strongly with 
five RAIDD molecules and up to two additional weakly bound RAIDD monomers 
(Nematollahi et al, 2015). Aside from the involvement in caspase-2 activation, PIDD also 
plays a role in the NF-κB pathway, where it interacts with receptor interacting protein 1 
(RIP1) and NF-κB essential modulator (NEMO) (Janssens et al, 2005). PIDD can thus be 
regarded as a bifurcated regulator of either pro-death or pro-survival signaling. What 
determines which of the two possible outcomes that will be “selected”, is the level of PIDD 
processing. Initially the leucine-rich repeats are removed through auto-cleavage, generating a 
DD-containing fragment denoted PIDD-C. This fragment can then either become further 
processed to generate PIDD-CC, thereby leading to caspase-2 activation, or form a complex 
with RIP1 and NEMO, resulting in the recruitment of NF-κB (Tinel et al, 2007).  
 
 
Figure 2. PIDDosome-mediated activation of caspase-2. Image reused with permission from Portland Press 
(Ribe et al, 2008). 
 
Although PIDD and RAIDD are involved in the activation of caspase-2, in vivo studies using 
pidd-/- and raidd-/- mice have shown that caspase-2 can nevertheless become activated (Manzl 
et al, 2009, Kim et al, 2009). Based on these findings it became evident that although the 
PIDDosome have the ability to promote caspase-2 activation, it is not indispensable for this 
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task. As it turns out, caspase-2 can also utilize the death-inducing signaling complex (DISC) 
as an activation platform (Olsson et al, 2009, Lavrik et al, 2006). The DISC is comprised of 
proteins belonging to the death receptor family, as well as caspase-8 and the protein Fas-
associated protein with death domain (FADD), where the latter functions as an adapter 
between the death effector domain (DED) and the death domain (DD) in the two former 
factors (Guicciardi and Gores, 2009). In order for caspase-2 to become activated through 
DISC, it appears that functional caspase-8 needs to be present, as inhibition of the latter 
abolishes the activation of the former (Olsson et al, 2009). Surprisingly this type of receptor-
stimulated processing of caspase-2 does not necessarily couple with apoptosis (Lavrik et al, 
2006). 
Two known isoforms of caspase-2 exists due to messenger RNA (mRNA) splicing. The first 
isoform encodes a 435 amino acid protein denoted caspase-2L, which induces cell death upon 
overexpression. Conversely, the second isoform encodes the anti-apoptotic 312 amino acid 
protein, caspase-2S. Although many tissues express both variants, there seem to be some 
degree of tissue-specificity as well. For instance, only caspase-2L was expressed in the 
murine thymus, whereas caspase-2S was the highest in the embryonic brain (Wang et al, 
1994). Interestingly, leukemic cells treated with the anti-cancer agent etoposide seemingly 
suppress caspase-2L levels, while increasing caspase-2S (Wotawa et al, 2002). Similarly, the 
anti-apoptotic form was expressed in human macrophages following etoposide and 
camptothecin treatment, and was observed to be highly expressed in macrophage-derived 
foam cells found around the core of atherosclerotic plaques (Martinet et al, 2003). These 
findings may suggest that caspase-2S is initially expressed after cells are exposed to agents 
causing DNA strand breaks, in order to delay apoptosis and allow DNA repair to commence. 
 
Substrates 
Despite being a highly conserved protein, there are few known substrates that are specific for 
caspase-2. Golgin-160, however, has been demonstrated to become cleaved by caspase-2 at a 
site unique for the protease, following apoptotic induction. Other caspases, recognizing 
similar peptide sequences as caspase-2, did not cleave golgin-160 at the same location albeit 
at other sites (Mancini et al, 2000). Another reported substrate of caspase-2 is the pro-
apoptotic protein BID. Although BID is also processed by caspase-8 at higher efficiencies, 
caspase-2 can nevertheless cleave the protein at Asp59, leading to cytochrome c release and 
apoptosis (Guo et al, 2002). In addition, following DNA damage caused by treatment with 
doxorubicin, caspase-2 has been reported to cleave mouse double minute 2 (MDM2) at 
Asp367, thereby protecting p53 from being targeted for proteasomal degradation. The 
truncated MDM2 can additionally bind to p53 to stabilize the tumor suppressor. Activation of 
caspase-2 in this context is PIDDosome-mediated, thus creating a positive loop where p53 
can promote its own activity. It is worth noting that caspase-3 was also able to process 
MDM2, although less efficient (Oliver et al, 2011). Taken together, these findings have 
revealed several settings in which caspase-2 can promote an apoptotic response. Since the 
substrates described are rarely unique for caspase-2, but can become equally processed by 
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other caspases, it may imply that caspase-2 mainly supports an already ongoing process and 
that the primary function of the protein is something else. 
 
Functions of caspase-2 
As previously mentioned, many different functions of caspase-2 have been proposed. Due to 
these cellular events often being closely related, while sharing many of the proteins involved, 
it is difficult to determine what the primary function of caspase-2 might be (Olsson et al, 
2015). The following section reviews some cellular processes to which caspase-2 has been 
associated.  
 
Cell death 
The hallmark function of initiator caspases is to trigger a cellular process, which culminates 
in the death of the cell. Caspase-2 has indeed been demonstrated to partake in several cases of 
induced cell death, which strongly supports the notion of it being a pro-cell death protein. For 
instance, caspase-2 is essential for triggering cell death in macrophages, which have been 
infected with strains of the intracellular parasite Brucella abortus (Chen and He, 2009, 
Bronner et al, 2013). Similarly, Salmonella-induced apoptosis in murine macrophages also 
appears to be dependent on the protein (Jesenberger et al, 2000). In a separate study, where 
epithelial cells were subjected to the pore-forming α-toxin (PFT) from Staphylococcus 
aureus, it was concluded that caspase-2 indeed functions as an initiator caspase. Cells with 
attenuated levels of caspase-2 display a significantly impaired PFT-mediated apoptotic 
response in this system (Imre et al, 2012). 
Infection with the Maraba rhabdovirus is known to elicit a strong endoplasmic reticulum 
(ER) stress response (Mahoney et al, 2011). ER stress is a condition in which unfolded 
proteins accumulate in the ER, to which cells respond by activating the unfolded protein 
response (UPR) in order to restore the protein folding homeostasis (Chen and Brandizzi, 
2013, Xu et al, 2005). Failure to do so will cause the UPR to trigger apoptosis as a means to 
eradicate and prevent the spread of the virus. During Maraba viral infections, caspase-2 
activation and subsequent cell death can be stimulated by downregulating inositol-requiring 
enzyme 1 alpha (IRE1α), an ER stress sensor responsible for activation of the UPR (Mahoney 
et al, 2011), which potentially reduce the time span that otherwise would be required to 
initiate apoptosis. The apoptotic modality following ER stress appears to involve BID 
cleavage by caspase-2. When this cleavage is blocked, by either downregulation or inhibition 
of caspase-2, it is sufficient to protect cells from apoptosis by the ER stress-inducing agents 
thapsigargin and brefeldin A (Upton et al, 2008). Interestingly, one group of researchers 
reported that IRE1α was responsible for cleaving certain microRNA (miRNA) to allow the 
translation of caspase-2 during ER stress (Upton et al, 2012). However, these findings 
partially contradict results by Mahoney and colleagues (2011). Moreover, in a separate study 
using several cell lines, no significant impact was observed on ER stress-induced apoptosis, 
following loss of caspase-2 (Sandow et al, 2014). 
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Aside from regulating cell death induced by microbial infections, caspase-2 also seems to 
control DNA-damage-induced apoptosis. Experiments made in p53 mutant zebrafish 
embryos, subjected to γ-irradiation, revealed a different apoptotic machinery which does not 
include activation of caspase-3 prior to DNA-fragmentation, nor is it affected by loss of p53 
or overexpression of the anti-apoptotic bcl-2/xl. Instead the process relies on ataxia 
telangiectasia mutated (atm), ATM and Rad3-related (atr) and caspase-2, following removal 
or inhibition of checkpoint kinase 1 (CHK1) (Sidi et al, 2008). The PIDDosome plays a role 
in this modality; ATM phosphorylates PIDD at Thr788, thereby allowing RAIDD to bind to 
PIDD. This is followed by the activation of caspase-2 (Ando et al, 2012). Nucleophosmin 
(NPM1) has similarly been shown to be important for DNA damage-induced PIDDosome 
assembly (Sidi and Bouchier-Hayes, 2017), further supporting the view of caspase-2 
mediating apoptosis during such conditions. Furthermore, PIDDosome-mediated caspase-2 
activation is also a prerequisite for cell death caused by treatment with cytoskeletal disrupting 
drugs. In MEFs lacking caspase-2, BID and BAX activation, as well as cytochrome c release, 
are delayed following treatment with vincristine, cytochalasin D, and paclitaxel (Ho et al, 
2008). These findings might suggest that caspase-2 is vital to prevent genomically abnormal 
cells from replicating. 
 
 
 
Figure 3. The relationship between caspase-2 and cell death. Image reused with permission from Springer 
Nature (Puccini et al, 2013b). 
 
Lipoapoptosis is a form of cell death emerging as a consequence of metabolic imbalance. 
When levels of unoxidized long-chain fatty acids (LCFAs) exceed the storage capabilities of 
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adipose tissues, the lipids start to accumulate in non-adipose tissues. This build-up can 
become toxic, causing an apoptotic cell death referred to as lipoapoptosis (Unger and Orci, 
2002, Johnson et al, 2013). When mammalian cells were treated with the LCFA palmitate, 
caspase-2 became activated, while down-regulation of the protease significantly diminished 
the apoptotic induction (Johnson et al, 2013). These findings strongly suggest that LCFAs are 
yet another trigger that can cause caspase-2 to initiate cell death. 
 
Oxidative stress and aging 
When a shift arises in the balance between oxidants and antioxidants, cells enter a state of so-
called oxidative stress. The resulting build-up of reactive oxygen species (ROS) can have 
harmful effects on cellular structures and processes, as well as on proteins, lipids and DNA 
(Birben et al, 2012, Betteridge, 2000). It is believed that aging is linked with cumulative 
damage to DNA and mitochondrial DNA, inflicted by ROS (Cui et al, 2012). Interestingly, 
caspase-2 has been associated with combating oxidative stress, as well as delaying the aging 
process in mice. These functions are thus separated from the well-established role in cell 
death, although one process cannot completely exclude the other. Caspase-2-/- mice suffer 
from hair loss and early hair graying, increased bone loss, reduced body weight and higher 
levels of oxidized proteins, compared to their wt controls (Zhang et al, 2007, Shalini et al, 
2012). Furthermore, hepatocytes from young or middle-aged caspase-2-/- mice appear to 
neutralize mitochondrial ROS at rates similar to those of old wt mice (Lopez-Cruzan and 
Herman, 2013). Comparably, caspase-2-/- MEFs have higher basal levels of peroxide and 
superoxide, as well as carbonylated proteins, compared with wt cells (Tiwari et al, 2014). 
Upon treatment with the oxidizing agent paraquat, caspase-2-deficient mice have been shown 
to display higher serum levels of the inflammatory cytokines IL-6 and IL-1β compared with 
controls (Shalini et al, 2015b). Taken together these findings suggest that caspase-2 regulates 
processes in order to mount a response towards increasing oxidative stress. Upon oxidative 
stress, caspase-2 appears to promote age-related muscle apoptosis in mice, with higher levels 
of processed caspase-2 found in older animals (Braga et al, 2008). In addition, old caspase-2-
deficient mice have been shown to exhibit increased damage caused by free-radicals and 
decreased activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD), 
compared with young mice of the same genotype. These findings are believed to be a 
consequence of reduced expression of the FoxO1 and FoxO3a genes, which are otherwise 
active during conditions of stress (Shalini et al, 2012). It may, therefore, be possible that 
caspase-2 functions as a transcriptional regulator in this context, perhaps in an age-depending 
manner. FoxO3a is known to regulate transcription of SOD during oxidative stress. Yet, the 
protein is also a known to inhibit proliferation and promote apoptosis, which contradicts its 
involvement in combating oxidative stress (Nho and Hergert, 2014). Moreover, it makes the 
role caspase-2 plays in this system much more questionable in the context of protecting the 
cell rather than promoting cell death during oxidative stress. This does, however, not rule out 
the possibility that caspase-2 responds differently towards oxidative damage, depending on 
the underlying cause. For instance, the protease has also been suggested to inhibit autophagy 
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following oxidative stress. Caspase-2-deficient neurons treated with rotenone, a complex I 
inhibitor of the mitochondrial respiratory chain, had enhanced levels of autophagy, eventually 
leading to necrosis due to overwhelming stress (Tiwari et al, 2011). On the other hand, wt 
neurons underwent apoptosis, indicating that the pro-apoptotic function may yet be the 
mechanism by which caspase-2 resolves the stressful conditions. Nevertheless, the protein 
does appear to harbor autophagy-suppressing properties, as caspase-2-/- cells displayed 
elevated levels of autophagic markers even under normal growth conditions, without any 
external stressors (Tiwari et al, 2014). Similar to this function, findings implicate caspase-2 as 
a suppressor of ROS-driven differentiation of macrophages into osteoclasts, upon treatment 
with the cytokine receptor activator of NF-κB ligand (RANKL) (Callaway et al, 2015).  
 
Metabolism 
Complementary to regulating the energy-providing mechanisms essential for life, metabolic 
processes are also able to control cell death (Green et al, 2014). If conditions favor growth, 
the cell death machinery is generally suppressed. Conversely, upon nutrient starvation several 
processes activate in response, such as a halt in proliferation and, as a last resort, apoptosis 
(Vakifahmetoglu-Norberg et al, 2017). Caspase-2 has been reported to be regulated by this 
fashion in Xenopus laevis oocytes (Nutt et al, 2005). When nutrient abundance was simulated 
by the addition of glucose-6-phosphate (G6P), a concomitant inhibition of apoptosis was 
observed. Further studies revealed that this was due to an inhibitory phosphorylation of 
caspase-2 at Ser135 (figure 4). As it turns out, addition of G6P increases levels of free 
coenzyme A (CoA), which in turn can directly bind to calcium/calmodulin-dependent kinase 
II (CaMKII). This interaction facilitates the binding of calmodulin (CAM) to CaMKII, 
leading to the activation of the latter. Subsequently, CaMKII catalyzes the inhibitory 
phosphorylation of caspase-2, thereby promoting oocyte survival (McCoy et al, 2013a, b). As 
a means to maintain the inhibition, the regulatory protein 14-3-3ζ binds to the phosphorylated 
caspase-2 and, by doing so, prevents dephosphorylation by protein phosphatase-1 (PP1) (Nutt 
et al, 2009). Interestingly, neither the binding of PP1 to caspase-2 nor the activity of the 
phosphatase appears to be metabolically regulated. In contrast, the metabolic processes 
control the interaction between 14-3-3ζ and caspase-2, causing either a lock-down or release 
of the protease. 
Other findings have emerged, hinting towards sex-specific metabolic functions of caspase-2. 
Reportedly, aged caspase-2-deficient male mice displayed decreased liver mass upon fasting 
compared to wt controls, although the total body weight remained unchanged. Contrary to 
this, female caspase-2-/- mice had reduced total body weight, but not liver mass (Wilson et al, 
2016). It thus becomes difficult to predict whether or not the presence of caspase-2 becomes 
an asset or liability when taken into a metabolic context. For instance, the protease has also 
been implied to promote obesity and non-alcoholic steatohepatitis (Machado et al, 2015, 
2016). When mice lacking caspase-2 were fed a Western diet (rich in fat), they did not 
notably develop any diabetes mellitus or non-alcoholic fatty liver disease, nor did they suffer 
from dyslipidemia, hepatic steatosis or abdominal fat deposition, strongly contrasting that of 
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wt mice (Machado et al, 2016). These reports would indicate that an overload in the lipid 
metabolism might become severe due to caspase-2. Perplexingly however, the protease might 
also be important during impaired fatty acid biosynthesis. Treatment of ovarian cancer cells 
with Orlistat, a fatty acid synthase inhibitor, was highly depending on caspase-2 for cell death 
induction (Yang et al, 2015). Taken together these findings show that metabolic processes 
can indeed regulate caspase-2, although it is still not determined if the function of the 
protease is solely related to cell death in this context. It is possible that caspase-2 exerts 
different activities, altogether dependent on the metabolic state of the cells. 
 
Figure 4. Overview of how nutrient abundance can cause an inhibition of apoptosis by modulating caspase-2. 
Image reused with permission from Springer Nature (Forsberg et al, 2017). 
 
Cancer and tumor suppression 
The caspase-2 locus is found in the long arm of human chromosome 7 (Kumar et al, 1995). 
This region is frequently deleted in tumors, especially in acute myeloid leukemias (Johansson 
et al, 1993, Holleman et al, 2005, Mrózek et al 2008). Although these findings would suggest 
that loss of caspase-2 would favor tumorigenesis, very few mutations in the coding region of 
the protease have been documented in tumors (Kim et al, 2011a, b). Still, reduced levels of 
caspase-2 mRNA (and protein) have been observed in cancer and tumor material, compared 
to normal tissues (Ren et al, 2012, Yoo et al, 2004). It might, therefore, be possible that the 
underlying cause leading to loss of the protein is not determined at the gene level. In the case 
of leukemia, loss of active caspase-2 correlates negatively in the context of therapeutic 
response, as well as survival outcome (Holleman et al, 2005, Estrov et al, 1998, Faderl et al, 
1999). Despite these findings, indicating a tumor suppressor function of caspase-2, the 
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opposite has been seen in neuroblastoma (Dorstyn et al, 2014). Based on data from an 
expression array on human neuroblastoma samples, it became evident that low levels of 
caspase-2 correlated with increased patient survival. This was however only true for MYCN-
non-amplified neuroblastomas, strongly suggesting that a potential tumor suppressing 
function may be context specific. 
Many experiments have been carried out in order to investigate how loss of caspase-2 might 
facilitate tumorigenesis. Somewhat surprisingly, caspase-2-/- mice do not display any increase 
in tumor incidence when compared to wt counterparts (Shalini et al, 2012, Zhang et al, 2007). 
In addition, loss of caspase-2 does not sensitize mice to develop cancers more readily than wt 
mice, following γ-irradiation or treatment with the DNA-damaging compound 3-
methylcholanthrene (Manzl et al, 2013, Manzl et al, 2012). What appears to be vital, 
however, is the p53 status, as loss of this protein accelerates tumorigenesis. For instance, 
although p53 levels was shown to be largely the same in caspase-2-/- and wt MEFs, caspase-2 
deficient cells had lower amounts of p21 transcripts (Ho et al, 2009). Since p53 is a known 
regulator of p21, these findings indicate that the function of p53 is impaired in caspase-2-/- 
cells. So far, only one study has shown that loss of caspase-2 can promote tumorigenesis 
following treatment with a DNA-damaging reagent (Shalini et al, 2016). When caspase-2-/- 
mice were injected with diethylnitrosamine (DEN), they consequently developed 
hepatocellular carcinoma at an increased rate compared to controls. DEN is a known inducer 
of ROS production, aside from being an agent that can alkylate DNA. This may imply that 
caspase-2 only limits tumor formation caused by a specific type of external agents. 
Interestingly, caspase-2 seems to act as a tumor suppressor in established tumor cells, driven 
by oncogenes (Ho et al, 2009, Manzl et al, 2012, Parsons et al, 2013, Puccini et al, 2013a). 
Caspase-2-/- MEFs, transformed with E1A/Ras, proliferated faster in vitro than transformed 
wt controls. Furthermore, the caspase-2-deficient MEFs quickly formed large colonies when 
grown in soft agar, compared to the slow growth of the transformed caspase-2+/+ cells. 
Similar results were observed when the MEFs were injected into nude mice, where caspase-
2-/-cells rapidly formed large and aggressive tumors, in stark contrast to the controls, which 
formed small or undetectable tumors (Ho et al, 2009). Eµ-Myc mice, a transgenic model, 
which readily develops lymphomas and leukemia, combined with knockout of caspase-2, 
resulted in accelerated tumorigenesis compared to Eµ-Myc mice alone (Ho et al, 2009). 
Although the underlying mechanism behind the potential tumor suppressive function of the 
protease still remains to be described, it has been concluded that it is PIDDosome-
independent (Manzl et al, 2012). Caspase-2 deficiency has also been reported to boost the 
formation of lymphomas caused by a loss of ATM (Puccini et al, 2013a). While atm-/- mice 
spontaneously acquire thymic lymphomas, atm-/-caspase-2-/- mice were shown to have a 
strong increase in tumor incidence. Moreover, offspring of the double-knockout animals died 
shortly after birth. The few that survived, displayed growth retardation compared to controls. 
There was no significant difference in the amount of apoptotic cells in the lymphomas, 
regardless of genotype. Yet atm-/-caspase-2-/- tumor cells proliferated faster than those from 
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atm-/--mice, indicating that the tumor suppressive function mediated by caspase-2 is not due 
to the apoptotic role of the protease (Puccini et al, 2013a). 
Aside from oncogene-driven lymphomagenesis, caspase-2 reportedly plays a role in the 
prevention and limitation of other types of cancer, such as murine breast cancer (Parsons et 
al, 2013) and lung cancer (Terry et al, 2015). Mice expressing the oncogene c-neu, under the 
transcriptional control of the mouse mammary tumor virus (MMTV) promoter, readily 
develop tumors in the mammary epithelium of multiparous mice. Consistent with 
observations made in the lymphoma models, caspase-2-/-MMTV animals displayed an 
acceleration in the tumor formation rate, when compared to caspase-2+/+MMTV mice 
(Parsons et al, 2013). Enhanced Kras-driven lung tumorigenesis has also been demonstrated 
following loss of caspase-2. The knockout-mice developed larger numbers of tumors, which 
were greater in size, than mice harboring one or both of the caspase-2 alleles. Although 
caspase-2-null tumors were more sensitive towards cisplatin compared to controls, they 
swiftly rebounded following a break in drug administration (Terry et al, 2015). These results 
are partly contrasting observations made in Eµ-Myc mice, where caspase-2-deficiency made 
cells resistant to chemotherapy-induced apoptosis (Ho et al, 2009). 
Taken together these findings indicate that loss of caspase-2 does not by itself increase the 
susceptibility of organisms to develop cancer, but rather makes it harder to halt the rapid 
growth of the established tumor(s). So far, the proposed tumor suppressive function appears 
to become a necessity for cells following oncogenic pressure, due to loss of other important 
proteins, or exposure to certain DNA-damaging agents. Cells that just lack caspase-2, without 
being subjected to additional genetic alterations, do not automatically turn tumorigenic. 
 
Preventing genomic instability 
Genomic instability is a term, which refers to changes in nucleic acid sequences (e.g. 
mutations) as well as alterations to the karyotype (e.g. aneuploidy). The former case is 
primarily caused by defects or inefficiencies in DNA-repair mechanisms, while the latter case 
can involve nearly all parts of chromosomal regulation (Heng et al, 2013). Both types of 
genomic alterations are hallmarks of cancer (Hanahan and Weinberg, 2011). If cells are 
unable to correct the damage, they typically undergo cell death in order to prevent the 
accumulation of defective cells (Roos and Kaina, 2006, Vitale et al, 2017). Whether genomic 
instability becomes a means for tumorigenic cells to shape their genomes in order to survive, 
or a “fail-safe” mechanism to bring about the destruction of cancer cells, still remains to be 
discussed (Forsberg et al, 2017). 
Several studies have shown that caspase-2 ostensibly promotes genomic stability. Whether or 
not this is directly linked to the proposed tumor suppressor function of the protease is still 
unclear, although the two modalities are intricately connected. Blood cells lacking caspase-2 
seemingly have deficient systems for maintaining a correct genome. Alas, T-cells from 
premalignant atm-/-caspase-2-/-mice displayed higher levels of aneuploidy (Puccini et al, 
2013a). Similar to this, bone marrow cells from old knockout mice suffered from increased 
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rates of aneuploidy and DNA-damage, while hematopoietic stem cell differentiation was 
impaired (Dawar et al, 2016). Other characteristics of genomic instability, observed upon loss 
of caspase-2, include micronuclei formation, abnormal mitoses, karyomegaly and 
multinucleation (Dorstyn et al, 2012, Parsons et al, 2013). Caspase-2-deficient MEFs treated 
with the compounds vincristine and paclitaxel, which target microtubule functions, were 
resistant to the apoptotic induction normally elicited by the two drugs (Ho et al, 2008). In the 
same line, splenocytes appear to require catalytically active caspase-2 to be able to get rid of 
aneuploid cells following treatment with mitotic poisons (Dawar et al, 2017). The ability for 
caspase-2 to process specific proteins does thus appear to be a requirement for maintaining 
genomic stability in certain biological contexts. For instance, colorectal cancers, caused by B-
cell lymphoma 9-like protein (bcl9l) dysfunction, display reduced basal levels of caspase-2 
mRNA and protein, which contributes to aneuploidy. Reportedly, upon faulty chromosomal 
segregation, functional BCL9L permits transcription of caspase-2, which can then either 
cleave MDM2 (thereby stabilizing p53) or BID (López-García et al, 2017). Both cases 
ultimately lead to apoptosis. 
A common trait pertaining to a role of caspase-2 in maintaining genomic integrity is the 
intricate connection the protease has with the cell cycle. For example, cyclin D3 expression 
has been shown to bring upon the activation of caspase-2, possibly by stabilizing the latter 
(Mendelsohn et al, 2002). Conversely, cyclin-dependent kinase 1 (CDK1) – cyclin B1 could 
suppress mitotic apoptosis by the inhibitory phosphorylation of caspase-2 at Ser340 (Andersen 
et al, 2009). Above all, caspase-2 is implied to partake in processes, which are active during 
malfunctioning mitosis. It was reported that an abnormal increase in centrosomes led to 
PIDDosome-mediated activation of caspase-2, resulting in cell cycle arrest (Fava et al, 2017). 
Similar to previous studies, this involved the cleavage of MDM2, stabilization of p53, and a 
p21-mediated halt in proliferation. Deficiencies in the checkpoints governing the DNA 
structure and spindle assembly can trigger a cell death response in mitosis, known as “mitotic 
catastrophe” (Castedo et al, 2004a). Although this was initially believed to be dependent on 
caspase-2 acting upstream of mitochondria, triggering activation of effector caspases and 
apoptotic cell death (Castedo et al, 2004b), it has also been shown to occur independently of 
caspase-2 in a necrotic manner (Vakifahmetoglu et al, 2008, Vitale et al, 2011). 
 
Neuronal maintenance 
Caspase-2 was originally identified as being a down-regulated protein during murine brain 
development (Kumar, 1992). Since then, a number of reports have implicated a possible 
function of caspase-2 in regulating neuronal cell death or survival. These findings are 
however elusive and seem to be highly context dependent. During the development of 
caspase-2-deficient mice, cell death of motor neurons was accelerated. Furthermore, 
sympathetic neurons deficient in caspase-2, isolated from the superior cervical ganglia, were 
more sensitive to cell death caused by nerve growth factor (NGF) deprivation than their wt 
counterparts (Bergeron et al, 1998). While these observations would indicate that the protease 
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acts in an anti-apoptotic manner, conflicting results have been obtained from other neurons. 
For instance, cells from the dorsal root ganglion of 2-day-old caspase-2-deficient mice were 
equally sensitive towards NGF withdrawal as controls (O'Reilly et al, 2002). Moreover, 
inhibition of caspase-2 protected adult glia and dorsal root ganglion neurons from cell death 
following serum deprivation (Vigneswara et al, 2013). Similarly, targeting caspase-2 with 
siRNA largely decreased the loss of retinal ganglion cells following axon clamping (Ahmed 
et al, 2011). 
Caspase-2 is believed to be involved in various neuropathological conditions, in addition to 
roles related with normal brain development. Loss of caspase-2 has been observed to reduce 
excitotoxicity-induced brain damage in neonatal mice (Carlsson et al, 2011). Furthermore, 
sympathetic and hippocampal neurons were greatly protected from cell death induced by β-
amyloid (which are peptides believed to cause Alzheimer’s disease) when caspase-2 was 
downregulated with antisense oligonucleotides (Troy et al, 2000). Likewise, caspase-2-
deficient mice were protected from the neurodegeneration caused by β-amyloid (Jean et al, 
2013). Aside from Alzheimer’s disease, unregulated caspase-2 does also seem to be part of 
the mechanisms leading towards developing Huntington’s disease. This may be dependent on 
the catalytic activity of the protease, as expression of an inactive mutant partly protected 
against Huntingtin-mediated cell death (Hermel et al, 2004). Moreover, caspase-2-deficient 
mice maintained higher degrees of motor functions, as well as cognitive functions, when 
compared with wt mice (Carroll et al, 2011). 
Collectively, research has shown an involvement of caspase-2 in the fate of neuronal cells. 
Due to contrasting findings, it becomes difficult to determine whether or not the protease 
promotes or inhibits cell death during brain development. The possibility exist that caspase-2 
performs various functions throughout the different developmental stages and may, therefore, 
adopt multiple characteristics depending on the timing. Furthermore, findings indicate that 
caspase-2 may be a contributing factor towards developing neurodegenerative diseases, 
although the precise mechanisms remain to be determined. 
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3 AIM OF THE STUDY 
The main aim of the PhD study was to characterize new processes involving caspase-2, as the 
protein is believed to be highly versatile. Although several, diverse functions have been 
proposed for caspase-2, few interaction partners of the protease have been described. 
Therefore, a yeast two-hybrid (Y2H) screen was carried out in order to identify potential 
interacting proteins, while using the full-length caspase-2 as bait. Based on the results from 
the screen and the established view/knowledge of caspase-2 acting as an initiator of apoptosis 
following DNA damage, three individual projects were formed, with the specific aims as 
follows: 
 
Paper I – To investigate an interaction between caspase-2 and RFXANK, and the extent of 
which this interaction would affect MHC II expression. 
 
Paper II – To study the involvement of caspase-2 in FAN-mediated processes, as well as 
confirming the interaction between the two proteins. 
 
Manuscript I – To evaluate the potential role caspase-2 would play in Gemtuzumab 
ozogamicin-induced cell death.  
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4 MATERIALS AND METHODS 
 
Cell lines 
 
Cells were grown in either RPMI-1640 or DMEM (supplemented with 10% heat-inactivated 
fetal bovine serum and 100 U/mL penicillin, 100 µg/mL streptomycin), with the exception of 
OCI-AML2 cells which were grown in alpha-modified MEM (20% heat-inactivated fetal 
bovine serum and 1% L-glutamine). 
The cell lines used in the papers and manuscript, included in this thesis, are listed in Table I. 
 
Table I. Cell lines employed in the studies. 
Cell line Origin (disease) Cell type Culture medium 
Daudi wt Burkitt's lymphoma B lymphoblast RPMI-1640 
HCT116 wt Colorectal carcinoma Epithelial DMEM 
HEK293T wt   Epithelial DMEM 
HEK293T shCtrl   Epithelial DMEM 
HEK293T shCasp2   Epithelial DMEM 
HeLa wt Cervical carcinoma Epithelial DMEM 
HeLa shCtrl   Epithelial DMEM 
HeLa shCasp2   Epithelial DMEM 
HL60 wt Acute promyelocytic leukemia Myeloid RPMI-1640 
OCI-AML2 wt Acute myeloid leukemia Myeloid MEM 
OCI-AML2 shCtrl   Myeloid MEM 
OCI-AML2 shCasp2   Myeloid MEM 
THP1 wt Acute monocytic leukemia Monocyte RPMI-1640 
THP1 shCtrl   Monocyte RPMI-1640 
THP1 shCasp2   Monocyte RPMI-1640 
 
 
Protein extraction and quantification 
 
Adherent cells were detached from culture vessels by adding trypsin directly to the cells. All 
cells were centrifuged at 1000 rpm (≈200 rcf) for 5 minutes, and subsequently washed in 
phosphate-buffered saline (PBS). This was followed by another centrifugation before 
removing the supernatant. Cells were then lysed for 10 minutes at room temperature in 
cOmplete™ Lysis-M, supplemented with protease inhibitors (Roche Diagnostics). 
Subsequently each sample was centrifuged for 5 minutes at 13 000 rcf, before collecting the 
supernatants. Protein concentrations were measured using the BCA Protein Assay (Thermo 
Fisher Scientific). The samples were then mixed with 5x Laemmli buffer and stored at -20oC.  
 
Western blot 
 
Western blot is semi-quantitative technique which can be used for comparing protein levels 
between different samples. For this reason, the technique was used in all projects of this 
thesis. Briefly, quantified protein samples were denatured at 95-97oC for 10 minutes, before 
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being separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE). The separated proteins were then electroblotted to 0.45 µm nitrocellulose 
membranes, which were subsequently blocked with 5% (w/v) non-fat dry milk in PBS for 60 
minutes at room temperature. Incubation with primary antibodies was carried out overnight at 
4oC. Membranes were then washed repeatedly with PBS and PBS-Tween20 (0.1%). 
Horseradish peroxidase (HRP)-conjugated, or fluorophore-labeled secondary antibodies were 
subsequently added, and the membranes were left to incubate at room temperature for 60 
minutes. This was again followed by repeated washing steps. Finally, proteins were detected 
by using enhanced chemiluminescence (ECL) (in cases when HRP-conjugated antibodies 
were utilized), or measuring fluorescence using the 700 nm and 800 nm channels. 
Densitometric analysis was carried out using the Image J software. 
 
Immunoprecipitation 
 
One method that can be used for studying protein-protein interactions is 
immunoprecipitation. Typically, the protein of interest can be captured while using 
immobilized antibodies. If the protein of interest is interacting with other proteins, these 
could potentially become co-captured. This method was, therefore, selected for studying the 
interactions between caspase-2 and RFXANK or FAN. In some settings, tagged versions of 
the three proteins were overexpressed prior to the protein extraction, in order to facilitate 
capture. The capture antibodies (targeting either the proteins directly, or the tags) were 
immobilized on magnetic beads. Cells were lysed in NP40-buffer (with added protease and 
phosphatase inhibitors) and centrifuged at 16000 rcf for 20 minutes. The supernatants, 
containing proteins, were then collected. Each protein sample was then added to the bead-
antibody mixtures, and placed under rotation overnight at 4oC. The following day, the 
samples were washed repeatedly using the lysis buffer, before being resuspended in Laemmli 
buffer. 
 
ELISA 
 
IL-6 secretion was measured using the IL-6 Quantikine® ELISA kit (R&D Systems), 
according to the manufacturer’s protocol. 
 
Fluorescent imaging 
 
Fluorescent microscopy was applied in order to study co-localization of proteins, as well as 
cellular effects. For this purpose, mCherry-, GFP-, or RFP-tagged versions of the proteins 
were overexpressed in cells. Nuclei were stained using Hoechst 33342. Lysosomes were 
stained using LysoSensor™ Green DND 189 (Invitrogen), according to the manufacturer’s 
protocol. Images were acquired with a Zeiss LSM 510 META confocal laser scanner 
microscope (Carl Zeiss MicroImaging).  
 
Cell proliferation assay 
 
An assay using Cell Proliferation Reagent WST-1 (Roche) was performed in order to confirm 
that shRNA-mediated knockdown of caspase-2 would not affect proliferation rates of the 
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cells. This was carried out according to the manufacturer’s recommendations. Absorbance 
was measured at 450 nm, with a reference wavelength at 650 nm. 
 
Cellular fractionation 
 
In addition to fluorescent microscopy, the localization of proteins can be determined by first 
fractionating the cellular compartments, followed by detection with e.g. western blot. This 
method was, therefore, used in combination with immunoprecipitation, in order to further 
evaluate where the interaction between caspase-2 and RFXANK takes place. Harvested cells 
were resuspended in a fractionation buffer (150 mM KCl, 1 mM MgCl2, 0.2 mM EGTA, 5 
mM Tris, and 0.01% digitonin) and left to incubate for 10 minutes at room temperature. 
Subsequently, samples where centrifuged and the supernatants (cytoplasmic fractions) were 
separated from the pellets (nuclear fractions). Immunoprecipitation was then carried out on 
the different fractions. 
 
Wound-healing assay 
 
The wound-healing assay, also known as a scratch assay, is a technique which can be used for 
studying cell migration. This method was, therefore, selected when investigating the effect of 
caspase-2-deficiency, as well as FAN-deficiency on cell motility. Cells with attenuated levels 
of the two proteins were grown in 6-well plates. When the cells had formed a monolayer, 
upon complete confluency, a scratch was made in the cell layer and initial (t0) images were 
obtained, using a Nikon microscope. This was repeated each day until cells had successfully 
repopulated the scratched areas. Cell-free areas in each image were measured using the 
wound-healing plugin in the Image J software. 
 
Yeast two-hybrid screen 
 
Yeast two-hybrid screening is a commonly used approach for discovering interacting 
proteins. For this reason, the technique was applied in order to identify proteins with the 
potential to interact with caspase-2. The screen was performed by Hybrigenics Services, 
Paris, France.  
 
Sphingolipid analysis 
 
Quantitative measurements of sphingolipids in caspase-2-deficient and control cells were 
carried out by the Medical University of South Carolina, Department of Biochemistry and 
Molecular Biology. This was done using HPLC-MS/MS, as has been described previously by 
Bielawski and coworkers (2009).  
 
Transfection of cell lines 
 
In some cases, prior to performing immunoprecipitation or fluorescent imaging, constructs 
encoding tagged RFXANK or NSMAF (FAN) were overexpressed in cells. These constructs 
were purchased from OriGene. Transfection was carried out using Lipofectamine® LTX 
(Invitrogen), according to the manufacturer’s recommendations. The same procedure was 
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applied when expressing catalytically inactive (and tagged) caspase-2, control plasmids, and a 
tagged construct corresponding to the four ankyrin repeats of RXANK.  
 
For the transfection of THP1 cells with siRNA constructs, HiPerFect® Transfection Reagent 
(Qiagen) was used, according to the manufacturer’s protocol. 
 
Transfection of yeast cells 
 
To confirm that the bait fragment (used in the Y2H screen) indeed encoded caspase-2, the 
construct was expressed in Saccharomyces cerevisiae W303a. The cells were vortexed and 
transfected by heat-shock for 45 minutes at 42°C, before being centrifuged and recovered in 
YPD (1% yeast extract, 2% peptone, 2% dextrose w/v). Cells were then plated on a selective 
plate (synthetic defined medium without tryptophan). During the following days, individual 
colonies were selected, from which overnight cultures were made. Proteins then were 
obtained from the cells by performing a Rödel extraction. Briefly, harvested cells were 
resuspended in H2O, before adding 50 µL Rödel mixture (741 µL H2O, 185 µL 10 M NaOH, 
74 µL 14.3 M β-mercaptoethanol). Subsequently, each sample was left on ice for 10 minutes, 
before adding 60 µL 72% trichloroacetic acid. This was followed by 20 minutes incubation at 
-20oC, and thereafter 30 minutes of centrifugation at 28,000 rcf. Finally, pellets were washed 
with acetone, before being resuspended in Laemmli buffer.  
 
Flow cytometric analysis 
 
Flow cytometry is a technique employed for counting and sorting cells, based on different 
parameters. This method was, therefore, used in order to estimate the surface distribution of 
MHC class II proteins on a wide range of murine antigen presenting cells. Murine B-cells 
were obtained through fluorescent-activated cell sorting (FACS), using a BD Aria III FACS 
sorter. 
 
Analysis of caspase-3 activation and conformational changes of BAX were carried out on 
0.5% PFA-fixed cells, using anti-caspase-3 and anti-BAX antibodies. 
 
Pulsed field gel electrophoresis 
 
In order to quantify DNA double strand breaks caused by GO-treatment, pulsed field gel 
electrophoresis (PFGE) was carried out according to a protocol presented by Stenerlöw et al, 
2003. Prior to the treatment, cells were cultured for 48 hours in 1000 Bq/mL 14C-thymidine-
containing medium. 
 
Statistical analysis 
 
Results are presented as means ± standard deviations.   
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5 RESULTS 
 
Paper I 
Forsberg J, Li X, Akpinar B, Salvatori R, Ott M, Zhivotovsky B, Olsson M (2018). 
A caspase-2-RFXANK interaction and its implication for MHC class II expression. 
Cell Death and Disease, 9: 80 
In this project, we aimed at investigating the potential interaction between caspase-2 and 
RFXANK. To date, RFXANK is only known for being involved in transcriptional regulation 
of Major histocompatibility complex II (MHC II) genes. RFXANK forms a complex with 
RFX5 and RFXAP, which then binds to the X-box motif of MHC II gene promoters. 
Subsequently, the Class II transactivator (CIITA) interacts with the bound factors, thereby 
initiating transcription. Based on this, we hypothesized that a caspase-2-RFXANK interaction 
could either promote or inhibit expression of MHC II. Since MHC II is primarily expressed 
by antigen-presenting cells (APCs), the majority of the experimental work was performed on 
cells belonging to this category.  
The study started with the confirmation of the construct used in the screen as bait. Indeed, the 
construct encoded a full-length caspase-2 protein, as was seen when expressed in S. 
Cerevisiae. Next, the interaction between caspase-2 and RFXANK was confirmed by co-
expressing tagged versions of the two proteins followed by immunoprecipitation. The 
caspase-2 construct encoded a catalytically inactive form of the protein, tagged to mCherry. 
This not only allowed us to overexpress caspase-2 without causing an induction of apoptosis, 
but also facilitated IP. The RFXANK construct was purchased from OriGene, and contained 
myc-DDK tags. IP results, both while overexpressing the constructs, as well as on 
endogenous material from B-cells, showed that the two proteins indeed can interact. This was 
also suggested when visualizing overlapping localization through fluorescent microscopy. 
Moreover, when expressing a construct consisting only of the four ankyrin repeats of 
RFXANK, the interaction with caspase-2 could still be observed, indicating that this region is 
important for forming a complex. Next, we decided to look at how loss of caspase-2 would 
affect MHC II expression. Surprisingly, we could not detect any differences in the surface 
expression of MHC II in APCs originating from thymus, the bone marrow or spleen of 
caspase-2-/- mice. However, when analyzing total lysates of B-cell lines, or B-cells from 
caspase-2-deficient mice, there was a clear induction of MHC II following loss of caspase-2. 
These findings suggest that caspase-2 exhibits a negative effect on MHC II gene expression, 
while other mechanisms control the installment of the protein at the cell surface. 
In conclusion, the data from this study show that caspase-2 can interact with RFXANK, and 
might, therefore, influence the regulatory processes of the immune system. 
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Paper II 
Forsberg J, Li X, Zamaraev AV, Panaretakis T, Zhivotovsky B, Olsson M (2018). 
Caspase-2 associates with FAN through direct interaction and overlapping 
functionality. Biochemical and Biophysical Research Communications, 499: 822-828 
FAN is a protein which has been reported to bind to a specific region on TNF receptor 1 
(TNFR1), where it is involved in TNF-α-mediated activation of neutral sphingomyelinase 
(nSMase), cell migration, IL-6 secretion and vesicular/lysosomal dynamics (Montfort et al, 
2010). 
Since caspase-2 was suggested to interact with FAN in the yeast-2-hybrid screen, we set out 
to investigate the impact this interaction would have on the known FAN-mediated processes. 
Similar to as in Paper 1, the interaction was confirmed by immunoprecipitation while 
overexpressing tagged versions of the two proteins. Based on the fact that FAN is an 
important factor in nSMase activation and ceramide production, we decided to evaluate how 
loss of caspase-2 would affect these processes. Caspase-2 levels were reduced in HEK293T 
and HeLa cells through shRNA-mediated knockdown, which was followed by measurements 
of the sphingolipid contents using HPLC-MS. No significant differences were observed in the 
quantity of the measured ceramide species when comparing control cells with caspase-2-
deficient cells. This indicates that caspase-2 is not involved in ceramide production, at least 
not in unstimulated cells. Next, we looked into how caspase-2 would influence IL-6 
secretion, keeping in mind that FAN-deficiency has been reported to attenuate IL-6 levels. 
Using ELISA, it was concluded that loss of caspase-2 impaired the secretion of IL-6 into the 
culture media, regardless of whether or not cells had been treated with TNF-α. In addition, 
confocal microscopy revealed that caspase-2 and FAN-deficient cells contained enlarged 
endosomal/lysosomal structures, possibly reflecting abnormal vesicular traffic. Wound-
healing assays further demonstrated that loss of caspase-2 decreases cells ability to migrate. 
Thus, although caspase-2-deficient cells were still able repopulate cell-free areas, they did so 
at a reduced rate compared with controls. 
Together these findings show that caspase-2 is able to influence a wide range of cellular 
processes, and acts in a similar fashion as FAN. Since the two proteins are able to interact, it 
is highly possible that caspase-2 acts together with FAN to regulate these modalities.  
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Manuscript I 
Hååg P, Lagergren Lindberg M, Forsberg J, Olsson M, Zielinska Chomej K, Zong D, 
Kanter L, Stenerlöw B, Lewensohn R, Viktorsson K, Zhivotovsky B, Stenke L. 
Caspase-2 is a mediator of apoptotic signaling in response to gemtuzumab ozogamicin 
in AML (manuscript, in revision). 
Acute myeloid leukemia (AML) is the most prevalent acute leukemia in adults. The disease 
has a poor outcome, where only 25% of patients survive a 5-year period. Treatment of AML 
typically involves high-dose chemotherapy. Although complete remission is often achieved, 
most patients eventually relapse with a chemo-resistant form of leukemia. Due to this, 
different ways for treating AML patients are currently being investigated. One such approach 
involves targeted delivery of cytotoxic agents to the leukemic cells, where surface proteins on 
the cells act as beacons. CD33 is transmembrane glycoprotein, which is found in normal 
myeloid cells, albeit the expression levels are elevated in AML blasts. Utilizing this is the 
antibody-drug conjugate Gemtuzumab ozogamicin (GO; Mylotarg®). GO consists of a 
humanized antibody that is directed against the CD33 antigen, and to which a derivative of 
calicheamicin γ1 is bound.  
In this study we showed that GO-mediated cytotoxicity involves the processing of caspase-2. 
Inhibition of the proteolytic activity of caspase-2 reduced the GO-induced activation of 
caspase-3. Similarly, removal of caspase-2 using siRNA caused the same outcome. 
Contrastingly, caspase-2 inhibition did not block BAX activation following GO-treatment, 
though it partially prevented BID processing. Expression levels of caspase-2 or caspase-3 did, 
however, not appear to be linked with the duration of complete remission for AML patients. 
Taken together, the findings show that GO-induced cell death in AML cells is to a great 
extent mediated by caspase-2, although the exact mechanism still remains to be determined. 
Despite this, GO also appears to be able to act in a caspase-2-independent manner to some 
degree.  
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6 DISCUSSION 
Cell death is a term encompassing tightly controlled cellular events, with several different 
modalities, leading to cell elimination. Although many of the proteins involved have defined 
properties in regulating the mechanisms of cell death, they also perform additional functions. 
Caspase-2 is a protease which originally was regarded as an initiator of apoptosis following 
DNA damage. Though this perception of the protease still holds true, it has become apparent 
that caspase-2 also partakes in processes which are not necessarily tied to cell death. As it 
appears, caspase-2 may very well function as a multi-regulatory protein to either enhance or 
suppress cellular processes. However, due to the lack of well-defined caspase-2-specific 
substrates or interacting partners (aside from during apoptosis), the protein still remains one 
of the least understood members of the caspase family. 
In the present study we aimed at discovering proteins which can interact with caspase-2, 
potentially in a non-cell death context. To identify these unknown proteins, we performed a 
yeast-2-hybrid screen, from which the two proteins RFXANK and FAN were suggested.  
MHC class II proteins are found on the cell-surface of antigen-presenting cells (Reith et al, 
2005), where they present extracellular proteins from pathogens to components of the 
immune system. Similar to MHC class I, class II proteins are heterodimers consisting of an α- 
and a β-chain. The expression of MHC II is mainly regulated at a transcriptional level (Reith 
et al, 2005). Central for this process are the trans-acting proteins RFX5, RFXAP, RFXANK 
and CIITA. While the three RFX-proteins are ubiquitously expressed in cells, CIITA 
expression is a highly regulated event. Together, RFX5, RFXAP and RFXANK form the so-
called RFX complex, which binds the X-box promoter motif of MHC II genes. CIITA can 
then interact with the bound complex in order to promote gene expression. Mutations in the 
four transactivators (in particular RFXANK) are known to cause MHC class II deficiency, 
resulting in a condition known as Bare lymphocyte syndrome (BLS) (Lisowska-Grospierre et 
al, 1994, Wiszniewski et al, 2003, Reith et al, 2005). In paper I we confirmed that caspase-2 
was able to interact with RFXANK in the cytoplasm of cells. This interaction appears to take 
place at the ankyrin repeat region of RFXANK. Ankyrin repeat motifs are known to mediate 
protein-protein interactions (Li et al, 2006). Moreover, in a report aiming at designing a 
caspase-2-specific inhibitor, the protease was demonstrated to possess binding properties 
towards ankyrin repeats (Schweizer et al, 2007). It is, therefore, not surprising that our results 
point towards an interaction taking place at this region. Furthermore, the ankyrin repeat 
motifs of RFXANK are responsible for the interaction with CIITA and RFXAP (Wiszniewski 
et al, 2003). Interestingly, dendritic cells can produce a CARD-containing splice-isoform of 
CIITA, which has the ability to inhibit caspase-mediated degradation of nitric oxide synthase-
2 or, conversely, promote the production of nitric oxide (NO). This, in turn, regulates the 
capability of dendritic cells to trigger T-cell activation/proliferation (Huang et al, 2010). In 
our study, while analyzing total protein levels from APCs, we observed a concomitant 
increase in MHC II following a loss of caspase-2. These findings indicate that caspase-2 can 
act as a suppressor of MHC II expression. While the mechanism is still unknown, it is 
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possible that caspase-2 binds to the ankyrin repeats of RFXANK, as well as the CARD on 
CIITA, thereby disrupting the interaction between the two trans-acting proteins. Moreover, 
cells with CARD-deficient CIITA are able to express functional MHC class II genes, 
suggesting that CIITA may be less “hampered” when losing the ability to bind caspases 
(Zinzow-Kramer et al, 2012). Surprisingly, we did not observe any clear differences in 
surface expression of MHC II on APCs from caspase-2-/- mice. While this seemingly 
contrasts the findings made on total protein levels, it may indicate that caspase-2 also affects 
mechanisms responsible for delivering MHC II to the plasma membrane. It is also important 
to note that no pathogenic pressure was applied during the experiments in paper I, which 
potentially could affect the surface distribution of MHC II.  
TNFR1 is a surface-bound receptor which is central in many signaling processes, such as cell 
survival, cell death induction and regulation of immune responses (Naudé et al, 2011). Upon 
ligand stimulation, the adaptor protein TRADD becomes recruited to the death domain of 
TNFR1 (Hsu et al, 1995). At this point the cell is presented with two possible pathways to 
follow, leading either to cell death or survival. If TRADD interacts with RIP1 and TRAF2, it 
will bring about the activation of NF-κB, which in turn leads to the expression of proteins 
involved in survival and/or inflammation (Hsu et al, 1996a, b). Conversely, if TRADD 
interacts with FADD and procaspase-8, thereby forming the DISC, it causes the activation of 
the caspase cascade and subsequent cell death (Muzio et al, 1996). TNFR1 can also induce 
caspase-3 activation and cell death via neutral sphingomyelinase (nSMase), in addition to 
acting through the DISC (Neumeyer et al, 2006). This alternative pathway results in the 
production of ceramides through the hydrolysis of sphingomyelin, a reaction catalyzed by 
nSMase. The adaptor protein FAN is essential for this TNF-α-induced activation of nSMase 
(Montfort et al, 2010). FAN binds to a specific domain of TNFR1, known as the NSD 
domain. This interaction is mediated through the PH and BEACH domains of FAN (Adam et 
al, 1996). While bound to TNFR1, the WD repeats of FAN allows nSMase to dock (Adam-
Klages et al, 1996). Aside from the critical role during nSMase activation, FAN is seemingly 
involved in other cellular processes as well. For instance, FAN is essential for full expression 
of the pro-inflammatory genes encoding IL-6 and CXCL2 (Montfort et al, 2009). 
Furthermore, FAN-deficient fibroblasts have been demonstrated to contain larger lysosomes 
compared with wild-type counterparts, possibly indicating a role in regulation of vesicular 
traffic (Möhlig et al, 2007, Montfort et al, 2010). In addition, FAN appears to be required for 
normal filopodia formation following TNF-α-stimulation (Haubert et al, 2007), and may, 
therefore, affect cell motility. While caspase-2 has been linked to death receptor biology 
(Espín et al, 2013, Olsson et al, 2009), no report had previously connected it to FAN. In 
paper II we showed that caspase-2 and FAN can interact when exogenously expressed. 
Moreover, when we systematically investigated the effect that caspase-2-depletion would 
have on cells, we noticed that the results greatly resembled those reported for FAN-
deficiency. IL-6 secretion greatly diminished when caspase-2 levels were reduced using 
shRNA-mediated knock-down. Cells deficient in caspase-2 also showed signs of reduced 
motility, as was demonstrated using wound-healing assays. Furthermore, caspase-2 deficient 
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cells contained large, spherical structures, indicating impaired vesicular/lysosomal 
homeostasis. Remarkably we did not observe any differences in the production of ceramide 
species, when comparing caspase-2-deficient cells with controls. This may indicate that a 
caspase-2-FAN interaction does not act to promote ceramide synthesis. However, it should be 
taken into account that we did not stimulate cells with TNF-α prior to the analysis, which 
may be required for triggering this specific pathway. Nevertheless, we showed that loss of 
caspase-2 causes the same outcomes as FAN-deficiency does, thus, supporting the hypothesis 
that the two proteins function together to regulate various processes. 
 
At a first glance, it would appear like the interactions we reported in papers I & II are 
connected to two different and unrelated functions. Interestingly, however, TNF-α has been 
demonstrated to influence MHC class II expression. Under normal conditions, MHC II 
expression is regulated to a great extent by the cytokine interferon gamma (IFN-γ). TNF-α 
has been shown to act synergistically with IFN-γ to induce expression of MHC II (Chang and 
Lee, 1986, Pfizenmaier et al, 1987, Arenzana-Seisdedos et al, 1988, Kim et al, 2002, Keller et 
al, 2011). On the other hand, in several other cases, TNF-α was found to antagonize the effect 
of IFN-γ on MHC II, thus, the link between TNF receptor-functions and MHC II appears to 
be very context specific (Makhoul et al, 2012, Melhus et al, 1991, Han et al, 1999). Factors 
determining the fate of MHC II expression seem to involve differentiation and maturation. 
For instance, TNF-α augments IFN-γ-mediated MHC II expression in the immature B-cell 
lines THP-1 and HL-60. However, when the cells were made to differentiate, the synergistic 
effect of TNF-α was lost (Watanabe and Jacob, 1991). Collectively, these findings highlight 
tightly regulated pathways, which to date are not fully understood. The precise role of 
caspase-2 in these processes, therefore, becomes a subject of speculation. Although a well-
described mechanism remains to be explained, it is highly possible that the protease partakes 
in the interconnection between TNFR1-functions and MHC class II regulation. The 
interaction with FAN could serve as a way to anchor caspase-2 to TNFR1. Upon stimulation, 
caspase-2 (and possibly also FAN) may dissociate from the receptor to allow interaction with 
RFXANK or other factors. This in turn prevents CIITA from interacting with the RFX 
complex, thereby reducing the expression of MHC class II genes. In this scenario, caspase-2 
acts as a second messenger, conveying the signal from the exterior of the cell to the nucleus. 
Since we were able to detect the caspase-2-RFXANK interaction in the cytosolic 
compartment, it is possible that caspase-2 shuttles RFXANK out from the nucleus, thus 
further preventing MHC II expression (figure 5). 
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Figure 5. A proposed explanation to how caspase-2 may suppress MHC class II gene expression by inhibiting 
the function of RFXANK. The image was made using templates from Laboratoires Servier.  
We have seen that, like FAN-deficiency, loss of caspase-2 seemingly disrupts normal 
vesicular traffic. This could potentially explain why we detected an increase in the total levels 
of MHC II when analyzing cell lysates, yet no clear difference in the surface expression of 
MHC II. Could it be that caspase-2-deficiency promotes the expression of MHC class II 
genes, yet prevents the encoded protein complex from being transported to the surface of the 
cell (figure 6)? Several reports have demonstrated how B-cells can secrete MHC II-
containing exosomes with the ability to elicit T-cell responses (Raposo et al, 1996, Buschow 
et al, 2010). Moreover, neutral sphingomyelinases are known to regulate the release of 
exosomes from the plasma membrane (Trajkovic et al, 2008, Menck et al, 2017). Although 
we did not observe any effects of caspase-2-deficiency on ceramide production, it is possible 
that a FAN-caspase-2 interaction mediates exosomal transport of proteins via nSMase. Loss 
of either caspase-2 or FAN could, by this mechanism, prevent the transport of MHC II to the 
surface of the cell (or release into the extracellular space). This could in turn connect to the 
observed impairment in cell migration (paper II), following ablation of FAN or caspase-2. 
As it turns out, MHC II is an important regulator of cell motility in both B- and T-cells 
(Partida-Sánchez et al, 2000, Fischer et al, 2007). It is, therefore, possible that loss of caspase-
2 or FAN subsequently traps MHC II in the cell interior, thereby preventing MHC II from 
promoting cell migration. Since FAN- and/or caspase-2-deficiencies are sufficient to impair 
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cell migration, a complimentary reduction in the surface expression of MHC II would 
possibly render APCs immobile. Another way in which caspase-2 could potentially regulate 
MHC II expression is by modulating IL-6. The cytokine IL-6 is known to inhibit expression 
of MHC II in a range of cells by various mechanisms (Kitamura et al, 2005, Abós et al, 
2016). In our study we observed that caspase-2-deficiency led to decreased secretion of IL-6. 
Although, the levels of MHC II were not investigated in the study (paper II), it is tempting to 
speculate that the observed increase in MHC II (presented in paper I) may be caused by 
attenuated secretion of IL-6, following a loss of caspase-2.  
 
 
Figure 6. A proposed explanation to how caspase-2 may be important for MHC II surface expression, by 
modulating vesicular traffic. Both caspase-2 and FAN-deficiency causes an accumulation of large 
vesicular/lysosomal structures. The image was made using templates from Laboratoires Servier. 
Caspase-2 is known to become activated when a cell sustains DNA damage. Depending on 
the situation, the protease is believed to regulate the cell cycle and maintenance of the 
genome. However, severe damage can lead to the activation of the pro-apoptotic function of 
caspase-2, as is often the case following chemotherapeutic treatment (Schmitt et al, 1999, 
Robertson et al, 2002, Olsson et al, 2009, Heikaus et al, 2010). One of the challenges with 
conventional chemotherapy is that the drugs generally affect both normal and tumorigenic 
cells. In addition, patients often relapse with chemo-resistant tumors that are increasingly 
aggressive. Due to this, there is a growing need for treatment strategies that specifically target 
tumor cells or, at least, completely eradicates them, thus ensuring complete remission. 
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Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) designed to specifically 
target AML cells. The drug binds to the CD33 antigen, leading to the internalization of the 
complex. Upon joining with lysosomes, the intercalating agent calicheamicin is released from 
the antibody conjugate, thereby causing DNA double strand breaks (Godwin et al, 2017). In 
manuscript I we showed that caspase-2 is involved in the cytotoxic response towards GO. 
HL60 cells treated with GO displayed clear apoptotic features. Furthermore, there was an 
increase in the cleavage of caspase-2, indicating the activation of the protease. Similar 
findings were seen in patient-derived cells, where full-length caspase-2 levels decreased after 
GO-treatment. Inhibition of the proteolytic activity of caspase-2, using z-VDVAD-fmk prior 
to GO-treatment, resulted in decreased caspase-3 activity. Likewise, siRNA-mediated 
knockdown of caspase-2 prevented GO-mediated activation of caspase-3. Together these 
findings indicate that caspase-2 acts upstream of caspase-3 during GO-induced cell death. 
Surprisingly, however, inhibition of caspase-2 did not appear to block GO-mediated BAX 
activation, although it slightly prevented BID processing. This may indicate that the 
involvement of caspase-2 in GO-mediated apoptosis is not necessarily tied to the main 
mechanism of action induced by the ADC. It is thus possible that the protease functions in a 
parallel pathway, following the sustained DNA damage caused by GO, where it acts like an 
augmenting factor in the cell death execution. Removal of caspase-2, or inhibition of the 
proteolytic activity, would therefore reduce the velocity of the apoptotic machinery but not 
completely block it. Another potential manner in which inhibition or removal of caspase-2 
could suppress the apoptotic response is if the protease is important for the uptake and 
processing of the drug itself. GO enters the cell through endosomes, which are eventually 
required to fuse with lysosomes in order to release the active compound calicheamicin. As 
described in paper II, loss of caspase-2 appears to disrupt the normal vesicular/lysosomal 
traffic. This raises the question whether or not caspase-2 mainly is important for the drug 
delivery process, rather than the actual cytotoxic mechanism. Partially supporting this 
hypothesis, are the findings that caspase-2 and caspase-3 expression levels, prior to treatment 
with GO, do not influence the duration of complete remission in AML patients (manuscript 
I). It is, therefore, possible that caspase-2 is of less importance for the drug effect, but rather 
pivotal for the uptake of the ADC. A third fashion, in which loss of caspase-2 could reduce 
the effectiveness of GO, would be if caspase-2 is an important regulator of cellular 
mechanisms by which GO exerts its function. For instance, DNA damage generally leads to a 
halt in the cell cycle in order to allow time for repair to commence. However, when the 
damage turns out to be irreparable, cell death is triggered as a final outcome. The purpose of 
this is to prevent faulty cells from replicating. Caspase-2 has repeatedly been implied to 
partake in the cell cycle, and is important for maintaining genetic stability (Oliver et al, 2011, 
Dorstyn et al, 2012, Fava et al, 2017). Impaired cell cycle arrest due to a loss of caspase-2, 
could thus result in that the GO-induced damage becomes “overlooked”, thereby reducing the 
potency of the drug. 
Taken together it is gradually becoming more apparent that caspase-2 possesses a variety of 
functions. What determines if and when the protease engages in a given modality, still 
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remains to be described in detail. So far caspase-2 has been reported to regulate cell death, 
maintaining genomic stability, suppressing tumorigenesis, combating oxidative stress and 
ageing, etc. Here we additionally report the ability of caspase-2 to regulate MHC class II 
expression, as well as being involved in TNF-receptor biology. The possibility exists that 
many of these functions are connected to each other, where the factors determining the 
outcome are highly context specific. Future studies should thus aim to cross-link the reported 
pathways in which caspase-2 partakes. 
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7 CONCLUSIONS AND OUTLOOK 
Caspase-2 is a protein which appears to be able to influence or regulate a wide range of 
cellular processes. In the presented studies, we show that caspase-2 is able to interact with the 
two proteins RFXANK and FAN. Loss of caspase-2 results in increased total levels of MHC 
class II proteins. Moreover, caspase-2 and RFXANK co-localize in the cytoplasm, but not in 
the nucleus. Collectively these findings indicate that caspase-2 acts as a suppressor of MHC 
II in antigen presenting cells. As this study did not involve any pathogenic pressure on the 
cells or animals, future studies should address this matter.  
While a lack of FAN has been reported to affect a multitude of processes, such as IL-6 
secretion, vesicular/lysosomal dynamics, cell migration and ceramide production, we show 
that loss of caspase-2 largely resembles that of FAN-deficiency. Attenuated caspase-2 levels 
impaired the ability of cells to repopulate cell-free areas. Likewise, IL-6 secretion was 
hampered upon loss of the protease. Presence or absence of caspase-2 does not appear to 
affect ceramide production under the experimental settings used here. However, large, 
abnormal vesicular structures were observed in caspase-2-deficient cells, indicating disrupted 
vesicular/lysosomal traffic.  
Since many FAN-mediated processes are important for a fully functioning immune system, it 
would be interesting to determine if caspase-2 plays a role in regulating the immune response 
as well. Stimulating the TNF-α pathways and subsequently evaluating the effect it would 
have on MHC II expression, could provide insights regarding whether or not caspase-2 
connects these two modalities. Strong hints would be if the co-localization between caspase-2 
and RFXANK or FAN would change following stimulation. Hypothetically, caspase-2 may 
be anchored to TNFR1 (through FAN), and upon stimulation with TNF-α, dissociates and 
forms a complex with RFXANK. This should be possible to confirm with 
immunoprecipitation following TNF-α-stimulation. 
The antibody-drug conjugate Gemtuzumab ozogamicin (Mylotarg®) induces apoptosis in 
AML cells. This seems to, at least in part, be acting through caspase-2, as inhibition or 
removal of the protease reduces caspase-3 activation. Although caspase-2 promoted BID 
processing, it did not affect BAX activation following treatment with GO. Whether or not 
caspase-2 is directly involved in the mechanism of action of GO, or rather acts in parallel, 
remains to be determined. Since the possibility exists that caspase-2-deficiency prevents 
proper delivery of GO, it would be interesting to evaluate if removal of the protease would 
also reduce GO-induced DNA damage. This could, in theory, be tested using comet assays on 
GO-treated caspase-2-deficient cells and controls. If the degree of DNA damage decreases 
following the removal of caspase-2, it could indicate a failure in calicheamicin (the active 
compound of GO) reaching the DNA.  
To date, several roles in different processes have been proposed for caspase-2, although 
direct, mechanistic explanations still remain largely unknown. One of the challenges in 
pinpointing a precise function of the protease arises due to the fact that the suggested 
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processes often are tightly related (figure 7). The work presented in this thesis demonstrates, 
for the first time, yet another involvement of caspase-2 in two additional areas of cell biology, 
namely immunologic regulation and TNF-mediated biology. These findings could potentially 
provide the research field with clues to what the true function of this enigmatic protein may 
be.  
 
Figure 7. The complexity of caspase-2 and the many processes in which it has been suggested to partake. 
Adapted from a figure by Olsson et al, 2015.  
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